Skip to content

Clinical trials

Fibrosis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibrosis Country / region: Australia Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20081
20092
20101
20111
20122
20131
20145
20162
20172
20183
20191
20201
20213
20231
20244
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated8
Active, not recruiting4
Recruiting3
Unknown status3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences4
Intercept Pharmaceuticals4
89bio, Inc.2
Blade Therapeutics2
Inventiva Pharma2
Vertex Pharmaceuticals Incorporated2
AbbVie1
AstraZeneca1
Axcella Health, Inc1
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibrosis34
Non-alcoholic Fatty Liver Disease7
Liver Diseases5
Lung Diseases5
Digestive System Diseases4
Fatty Liver4
Hepatitis C4
Liver Cirrhosis, Biliary4
Respiratory Tract Diseases4
Cystic Fibrosis3

Trials

Showing 51 to 34 of 34. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.